应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02480 绿竹生物-B
休市中 08-23 16:08:27
22.850
-0.050
-0.22%
最高
22.850
最低
22.850
成交量
1,200
今开
22.850
昨收
22.900
日振幅
0.00%
总市值
45.93亿
流通市值
45.93亿
总股本
2.01亿
成交额
2.74万
换手率
0.00%
流通股本
2.01亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
绿竹生物(02480)中期亏损扩大38.54% 研发开支同比增加142.41%
金吾财讯 · 08-21
绿竹生物(02480)中期亏损扩大38.54% 研发开支同比增加142.41%
绿竹生物-B(02480.HK)上半年净亏损达1.1亿元 研发开支同比增长142.4%
格隆汇 · 08-21
绿竹生物-B(02480.HK)上半年净亏损达1.1亿元 研发开支同比增长142.4%
绿竹生物-B(02480)发布中期业绩,净亏损1.1亿元,同比扩大38.5%
智通财经 · 08-21
绿竹生物-B(02480)发布中期业绩,净亏损1.1亿元,同比扩大38.5%
《业绩》绿竹生物-B(02480.HK)半年亏损扩大至1.1亿元人民币
阿斯达克财经 · 08-21
《业绩》绿竹生物-B(02480.HK)半年亏损扩大至1.1亿元人民币
下周备忘
阿斯达克财经 · 08-16
下周备忘
绿竹生物-B(02480.HK)拟8月21日举行董事会会议批准中期业绩
格隆汇 · 08-09
绿竹生物-B(02480.HK)拟8月21日举行董事会会议批准中期业绩
绿竹生物-B盘中异动 股价大涨7.20%
自选股智能写手 · 08-07
绿竹生物-B盘中异动 股价大涨7.20%
绿竹生物-B盘中异动 大幅下跌9.85%
自选股智能写手 · 08-05
绿竹生物-B盘中异动 大幅下跌9.85%
绿竹生物-B(02480)7月16日回购3400股
智通财经 · 07-16
绿竹生物-B(02480)7月16日回购3400股
绿竹生物-B(02480.HK)合共购回143.26万股
阿斯达克财经 · 07-16
绿竹生物-B(02480.HK)合共购回143.26万股
绿竹生物-B(02480)7月15日斥资2817.42万港元回购115.44万股
智通财经 · 07-15
绿竹生物-B(02480)7月15日斥资2817.42万港元回购115.44万股
【绿竹生物-B(02480.HK)7月15日斥资2817.42万港元回购115.44万股】智通财经APP讯,绿竹生物-B(02480.
智通财经 · 07-15
【绿竹生物-B(02480.HK)7月15日斥资2817.42万港元回购115.44万股】智通财经APP讯,绿竹生物-B(02480.
绿竹生物-B(02480)7月12日斥资663.04万港元回购27.82万股
智通财经 · 07-12
绿竹生物-B(02480)7月12日斥资663.04万港元回购27.82万股
绿竹生物-B(02480)出现大手买入44.88万股,成交价$23.65,涉资1.061千万
阿斯达克财经 · 07-09
绿竹生物-B(02480)出现大手买入44.88万股,成交价$23.65,涉资1.061千万
绿竹生物-B盘中异动 大幅下挫5.39%
自选股智能写手 · 07-08
绿竹生物-B盘中异动 大幅下挫5.39%
绿竹生物-B盘中异动 股价大跌5.00%
自选股智能写手 · 06-25
绿竹生物-B盘中异动 股价大跌5.00%
绿竹生物-B盘中异动 下午盘股价大跌5.47%
自选股智能写手 · 06-21
绿竹生物-B盘中异动 下午盘股价大跌5.47%
绿竹生物-B盘中异动 股价大跌5.01%报21.800港元
自选股智能写手 · 06-20
绿竹生物-B盘中异动 股价大跌5.01%报21.800港元
绿竹生物-B(02480)股价显著波动11.628%,现价港币$22.3
阿斯达克财经 · 06-19
绿竹生物-B(02480)股价显著波动11.628%,现价港币$22.3
绿竹生物-B(02480)股价上升5.581%,现价港币$22.7
阿斯达克财经 · 06-19
绿竹生物-B(02480)股价上升5.581%,现价港币$22.7
加载更多
公司概况
公司名称:
绿竹生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02480","market":"HK","secType":"STK","nameCN":"绿竹生物-B","latestPrice":22.85,"timestamp":1724400507030,"preClose":22.9,"halted":0,"volume":1200,"delay":0,"floatShares":201013032,"shares":201013032,"eps":-1.3742256,"marketStatus":"休市中","marketStatusCode":7,"change":-0.05,"latestTime":"08-23 16:08:27","open":22.85,"high":22.85,"low":22.85,"amount":27420,"amplitude":0,"askPrice":22.85,"askSize":800,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.5047736685092352,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"listingDate":1683475200000,"adjPreClose":22.9,"openAndCloseTimeList":[[1724376600000,1724385600000],[1724389200000,1724400000000]],"volumeRatio":0.9677418730489113,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02480","defaultTab":"news","newsList":[{"id":"2461814263","title":"绿竹生物(02480)中期亏损扩大38.54% 研发开支同比增加142.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461814263","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461814263?lang=zh_cn&edition=full","pubTime":"2024-08-21 16:54","pubTimestamp":1724230441,"startTime":"0","endTime":"0","summary":"金吾财讯 | 绿竹生物(02480)公布截至2024年6月30日止六个月的中期业绩。财报显示,公司拥有人应占期内亏损1.10亿元(人民币,下同),去年同期为7935.2万,亏损同比增长38.54%;每股基本亏损0.54元。不派中期股息。期内,集团研发开支8038万元,同比增加142.41%。主要由于截至2024年6月30日止六个月LZ901正在中国开展的III期临床试验。","market":"other","thumbnail":"https://static.szfiu.com/news/20200915/ODRiNzQzZTk0YTE3ODM5MDM0NGM4MGE1NDVjZDI1MDAyMzQwNjE1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/ODRiNzQzZTk0YTE3ODM5MDM0NGM4MGE1NDVjZDI1MDAyMzQwNjE1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1942761","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2461186814","title":"绿竹生物-B(02480.HK)上半年净亏损达1.1亿元 研发开支同比增长142.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461186814","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461186814?lang=zh_cn&edition=full","pubTime":"2024-08-21 16:50","pubTimestamp":1724230212,"startTime":"0","endTime":"0","summary":"格隆汇8月21日丨绿竹生物-B公布中期业绩,截至2024年6月30日止六个月,集团其他收入为人民币973.2万元,同比增长82.3%;期内亏损为人民币1.10亿元,亏损同比增长38.5%。研发开支为人民币8037.6万元,同比增长142.4%。于2024年上半年,公司已实现多项公司重大里程碑。于2023年9月在中国启动公司核心产品LZ901的多中心、随机、双盲、安慰剂对照III期临床试验后,公司于2024年1月已完成共26,000名40岁及以上健康受试者的入组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821165012ab5ecaf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821165012ab5ecaf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2461811474","title":"绿竹生物-B(02480)发布中期业绩,净亏损1.1亿元,同比扩大38.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461811474","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461811474?lang=zh_cn&edition=full","pubTime":"2024-08-21 16:48","pubTimestamp":1724230090,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿竹生物-B 发布截至2024年6月30日止六个月业绩,其他收入973.2万元,同比增长82.3%;研发开支8037.6万元,同比增长142.4%;净亏损1.1亿元,同比扩大38.5%;每股基本亏损0.54元。集团的研发开支由增加,乃主要由于截至2024年6月30日止六个月LZ901正在中国开展的III期临床试验。在此基础上,集团于2024年6月就LZ901举行中期总结会议,讨论其在中国的III期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1167654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2461811115","title":"《业绩》绿竹生物-B(02480.HK)半年亏损扩大至1.1亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2461811115","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461811115?lang=zh_cn&edition=full","pubTime":"2024-08-21 16:42","pubTimestamp":1724229720,"startTime":"0","endTime":"0","summary":"绿竹生物-B(02480.HK) 公布截至今年6月底止中期业绩,其他收入973.2万元人民币(下同),按年升82.3%。亏损扩大至1.1亿元,上年同期蚀7,935.2万元;每股亏损0.54元。不派息。过往派息公布日期派息事项派息内容2024/03/15末期业绩无派息2023/08/21中期业绩无派息公司透露,今年4月已于广东省珠海市完成二期生产设施的建设,该生产设施的规划建筑面积约12万平方米,其中7.2万平方米为生产厂房。(js/k)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230515123015341_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230515123015341_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1373681/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2459995972","title":"下周备忘","url":"https://stock-news.laohu8.com/highlight/detail?id=2459995972","media":"阿斯达克财经","labels":["Economic Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459995972?lang=zh_cn&edition=full","pubTime":"2024-08-16 18:05","pubTimestamp":1723802700,"startTime":"0","endTime":"0","summary":"8月19日(周一)新西兰7月央行服务业表现指数:前值40.2日本6月核心机械订单月率:预测转升0.9%;前值跌3.2%日本6月核心机械订单年率:预测升1.1%;前值升10.8%英国8月Rightmove房价指数年率:前值升0.4%英国8月Rightmove房价指数月率:前值跌0.4%美国7月咨商会领先指标:预测跌0.3%;前值跌0.2%业绩公布:恒安国际(01044.HK)、华润啤酒(00291.","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180504113903359_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180504113903359_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1372387&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Economic Data","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00425","02410","00081","02778","02899","01033","02380","02869","09979","03311","00173","01070","00548","06098","01816","02096","03668","01071","02057","02018","01224","00511","06969","06979","01530","01044","00386","09992","09690","02688","00780","02367","02480","02382","01833","01962","09997","09698","02878","09969","00097","00069","01036","00388","01368","03808"],"gpt_icon":1},{"id":"2458551919","title":"绿竹生物-B(02480.HK)拟8月21日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2458551919","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458551919?lang=zh_cn&edition=full","pubTime":"2024-08-09 17:00","pubTimestamp":1723194052,"startTime":"0","endTime":"0","summary":"格隆汇8月9日丨绿竹生物-B(02480.HK)宣布,公司将于2024年8月21日(星期三)举行董事会会议,以(其中包括)考虑及批准公司及其附属公司截至2024年6月30日止六个月的未经审核综合中期业绩以及考虑派发中期股息(如有)的建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809170052af96c6a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809170052af96c6a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2457832953","title":"绿竹生物-B盘中异动 股价大涨7.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457832953","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457832953?lang=zh_cn&edition=full","pubTime":"2024-08-07 09:56","pubTimestamp":1722995770,"startTime":"0","endTime":"0","summary":"2024年08月07日早盘09时56分,绿竹生物-B股票出现异动,股价快速拉升7.20%。绿竹生物-B股票所在的生物技术行业中,整体跌幅为0.36%。其相关个股中,再鼎医药、药明巨诺-B、绿竹生物-B涨幅较大,振幅较大的相关个股有来凯医药-B、歌礼制药-B、再鼎医药,振幅分别为9.92%、8.16%、6.94%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807095610aefd9dfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807095610aefd9dfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2457710283","title":"绿竹生物-B盘中异动 大幅下跌9.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457710283","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457710283?lang=zh_cn&edition=full","pubTime":"2024-08-05 15:58","pubTimestamp":1722844712,"startTime":"0","endTime":"0","summary":"2024年08月05日临近收盘15时58分,绿竹生物-B股票出现异动,股价大幅下跌9.85%。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,嘉和生物-B、乐普生物-B、泰格医药涨幅较大,振幅较大的相关个股有乐普生物-B、方达控股、宜明昂科-B,振幅分别为19.00%、18.52%、18.50%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080515583296823d6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080515583296823d6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2451969165","title":"绿竹生物-B(02480)7月16日回购3400股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451969165","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451969165?lang=zh_cn&edition=full","pubTime":"2024-07-16 17:57","pubTimestamp":1721123826,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿竹生物-B(02480)发布公告,于2024年7月16日斥资8.3万港元回购3400股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151593.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2451678567","title":"绿竹生物-B(02480.HK)合共购回143.26万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451678567","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451678567?lang=zh_cn&edition=full","pubTime":"2024-07-16 00:38","pubTimestamp":1721061480,"startTime":"0","endTime":"0","summary":"绿竹生物-B(02480.HK) 公布,7月12日及15日,于公开市场分别购回27.82万股及115.44万股,合共143.26万股,占公司总股本0.71%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-07-15 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230515123015891_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230515123015891_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1363758/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2451648542","title":"绿竹生物-B(02480)7月15日斥资2817.42万港元回购115.44万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451648542","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451648542?lang=zh_cn&edition=full","pubTime":"2024-07-15 18:56","pubTimestamp":1721041012,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿竹生物-B(02480)发布公告,于2024年7月15日该公司斥资2817.42万港元回购115.44万股,回购价格为每股24.05-24.45港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2451648503","title":"【绿竹生物-B(02480.HK)7月15日斥资2817.42万港元回购115.44万股】智通财经APP讯,绿竹生物-B(02480.","url":"https://stock-news.laohu8.com/highlight/detail?id=2451648503","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451648503?lang=zh_cn&edition=full","pubTime":"2024-07-15 18:56","pubTimestamp":1721041012,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2450558368","title":"绿竹生物-B(02480)7月12日斥资663.04万港元回购27.82万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450558368","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450558368?lang=zh_cn&edition=full","pubTime":"2024-07-12 18:58","pubTimestamp":1720781909,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿竹生物-B(02480)发布公告,于2024年7月12日该公司斥资663.04万港元回购27.82万股,回购价格为每股23.45-24.05港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2450094467","title":"绿竹生物-B(02480)出现大手买入44.88万股,成交价$23.65,涉资1.061千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2450094467","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450094467?lang=zh_cn&edition=full","pubTime":"2024-07-09 16:01","pubTimestamp":1720512060,"startTime":"0","endTime":"0","summary":"[大手成交]绿竹生物-B(02480)在下午04:01出现大手买入,成交量为44.88万,成交价为港币$23.65,涉资1.061千万。至目前为止,股价无升跌,今日最高价为$23.65,而最低价为$23.3,总成交量为44.9万股,总成交金额港币$1.062千万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2407093956/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2449445746","title":"绿竹生物-B盘中异动 大幅下挫5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449445746","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449445746?lang=zh_cn&edition=full","pubTime":"2024-07-08 13:57","pubTimestamp":1720418257,"startTime":"0","endTime":"0","summary":"2024年07月08日下午盘13时57分,绿竹生物-B股票出现异动,股价急速下跌5.39%。绿竹生物-B股票所在的生物技术行业中,整体跌幅为2.01%。其相关个股中,瑞科生物-B、歌礼制药-B、基石药业-B涨幅较大,振幅较大的相关个股有晶泰科技、方达控股、荣昌生物,振幅分别为18.94%、13.58%、12.69%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708135737941f4cf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708135737941f4cf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2446372852","title":"绿竹生物-B盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446372852","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446372852?lang=zh_cn&edition=full","pubTime":"2024-06-25 11:22","pubTimestamp":1719285745,"startTime":"0","endTime":"0","summary":"2024年06月25日早盘11时22分,绿竹生物-B股票出现波动,股价大幅下挫5.00%。截至发稿,该股报21.851港元/股,成交量400股,换手率0.00%,振幅4.78%。绿竹生物-B股票所在的生物技术行业中,整体跌幅为0.07%。绿竹生物-B公司简介:北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625112225941f0d26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625112225941f0d26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2445578368","title":"绿竹生物-B盘中异动 下午盘股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445578368","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445578368?lang=zh_cn&edition=full","pubTime":"2024-06-21 13:36","pubTimestamp":1718948218,"startTime":"0","endTime":"0","summary":"2024年06月21日下午盘13时36分,绿竹生物-B股票出现异动,股价快速下挫5.47%。绿竹生物-B股票所在的生物技术行业中,整体跌幅为0.46%。绿竹生物-B公司简介:北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062113365896815bbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062113365896815bbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2444252519","title":"绿竹生物-B盘中异动 股价大跌5.01%报21.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444252519","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444252519?lang=zh_cn&edition=full","pubTime":"2024-06-20 13:45","pubTimestamp":1718862335,"startTime":"0","endTime":"0","summary":"2024年06月20日下午盘13时45分,绿竹生物-B股票出现波动,股价大幅跳水5.01%。截至发稿,该股报21.800港元/股,成交量67.66万股,换手率0.33%,振幅0.00%。资金方面,该股资金流入4580港元,流出0港元。绿竹生物-B股票所在的生物技术行业中,整体跌幅为0.75%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620134536941efc38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620134536941efc38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2444299449","title":"绿竹生物-B(02480)股价显著波动11.628%,现价港币$22.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2444299449","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444299449?lang=zh_cn&edition=full","pubTime":"2024-06-19 15:05","pubTimestamp":1718780700,"startTime":"0","endTime":"0","summary":"[异动股]绿竹生物-B(02480) 股价在下午03:05出现显著波动11.628%,现股价为港币$22.3,比前收市价上升3.721%3.721%。至目前为止,今日最高价为$22.7,而最低价为$20.2。总成交量为6000股,总成交金额为港币$12.679万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112134424260_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112134424260_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAC24061939/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2444244514","title":"绿竹生物-B(02480)股价上升5.581%,现价港币$22.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2444244514","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444244514?lang=zh_cn&edition=full","pubTime":"2024-06-19 14:30","pubTimestamp":1718778600,"startTime":"0","endTime":"0","summary":"[上升股]绿竹生物-B(02480) 股价在下午02:30比前收市价上升5.581%,现股价为港币$22.7。至目前为止,今日最高价为$22.7,而最低价为$20.2。总成交量为5800股,总成交金额为港币$12.233万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2406195535/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02480"],"gpt_icon":0}],"profile":{"websiteUrl":"http://luzhubiotech.com","stockEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0399},{"period":"3month","weight":-0.0439},{"period":"6month","weight":-0.0519},{"period":"1year","weight":-0.2267},{"period":"ytd","weight":-0.2358}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.0174},{"period":"3month","weight":-0.0536},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0329},{"period":"ytd","weight":0.0331}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","exchange":"SEHK","name":"绿竹生物-B","nameEN":"LUZHU BIOTECH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"绿竹生物-B(02480)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供绿竹生物-B(02480)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"绿竹生物-B,02480,绿竹生物-B股票,绿竹生物-B股票老虎,绿竹生物-B股票老虎国际,绿竹生物-B行情,绿竹生物-B股票行情,绿竹生物-B股价,绿竹生物-B股市,绿竹生物-B股票价格,绿竹生物-B股票交易,绿竹生物-B股票购买,绿竹生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"绿竹生物-B(02480)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供绿竹生物-B(02480)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}